# Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers

> **NCT06864793** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Qilu Pharmaceutical Co., Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** QL1012D
- **DRUG:** Gonal-F®

## Key facts

- **NCT ID:** NCT06864793
- **Lead sponsor:** Qilu Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-06
- **Primary completion:** 2026-02-04
- **Final completion:** 2026-04
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864793, "Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06864793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*